Home Newsletters Extracellular Matrix News CTCFL Regulates the PI3K-Akt Pathway and It Is a Target for Personalized...

CTCFL Regulates the PI3K-Akt Pathway and It Is a Target for Personalized Ovarian Cancer Therapy

0
The authors used in vitro models to evaluate the transcriptional changes due to the presence of CTCFL, followed by a selection of gene candidates using de novo network enrichment analysis.
[npj Systems Biology and Applications]
7992332 {7992332:BBBBBBBB} apa 50 1 171593 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version